FMC-376 Clinical Trials (2026): 1 Studies for Advanced Solid Tumors With KRAS G12C Mutations & Colorectal Cancer
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 FMC-376 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Advanced Solid Tumors With KRAS G12C Mutations & Colorectal Cancer) and 403 total planned enrollment. 1 FMC-376 clinical trial is actively recruiting at 12 U.S. sites across 9 states. Most recent activity: NCT06244771 (Apr 2028).
Where to Participate: All FMC-376 Trial Sites in the U.S. (12 sites across 9 states)
Every actively recruiting FMC-376trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center | La Jolla92037 | NCT06244771 | Map |
| CA | University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center | San Francisco94158 | NCT06244771 | Map |
| IN | Northwest Cancer Centers | Dyer46311 | NCT06244771 | Map |
| KS | The University of Kansas Cancer Center | Fairway66205 | NCT06244771 | Map |
| MA | Dana-Farber Cancer Institute | Boston02215 | NCT06244771 | Map |
| MI | Karmanos Cancer Institute | Detroit48201 | NCT06244771 | Map |
| PA | University of Pennsylvania | Philadelphia19104 | NCT06244771 | Map |
| TX | The University of Texas MD Anderson Cancer Center | Houston77030 | NCT06244771 | Map |
| TX | South Texas Accelerated Research Therapeutics, LLC | San Antonio78229 | NCT06244771 | Map |
| TX | UT Health San Antonio | San Antonio78229 | NCT06244771 | Map |
| UT | START Mountain Region | West Valley City84119 | NCT06244771 | Map |
| VA | Virginia Cancer Specialists | Fairfax22031 | NCT06244771 | Map |
FMC-376 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1/P2 | 1 | 1 |
Recruiting FMC-376 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06244771 | PROSPERA Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors | P1/P2 | Advanced Solid Tumors With KRAS G12C Mutations | 403 | Feb 2024 |
All FMC-376 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06244771 | PROSPER | A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors | P1/P2 | recruiting | 403 | Frontier Medicines Corporation | Feb 2024 |
FMC-376 clinical trials: frequently asked questions
- How many FMC-376 clinical trials are there?
- 1 FMC-376 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are FMC-376 clinical trials recruiting in 2026?
- Yes — 1 FMC-376 trial is actively recruiting in 2026, with 12 U.S. sites across 9 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is FMC-376 being studied for?
- FMC-376 is being studied for Advanced Solid Tumors With KRAS G12C Mutations, Colorectal Cancer, KRAS G12C, Metastatic Solid Tumor, Non Small Cell Lung Cancer and 3 more. The trials are grouped by indication on this page.
- Who sponsors FMC-376 clinical trials?
- The lead sponsor across the most FMC-376 trials is Frontier Medicines Corporation. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming FMC-376as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: